Admin_Adham
Jump to Key Points The heart is among the organs least likely to develop cancer, a long-standing biological puzzle. A recent Science study offers a possible explanation. In mouse and engineered-tissue models, mechanical load from cardiac contractions suppressed tumor cell proliferation. Here are five key takeaways.
1. A Cardiac Conundrum
Tumors originating in heart muscle are extremely rare, appearing in fewer than 1% of autopsies. Cardiac metastases are found in up to 18% of autopsies, but these metastatic tumors are often small, incidental, and asymptomatic.
2. Beating Hinders Dividing
Cardiomyocytes chiefly stop dividing after birth. But in patients on left ventricular assist devices, which reduce the heart's workload, cardiac muscle cells show renewed signs of proliferation, suggesting that mechanical force normally restrains them.
3. Load vs. Tumor Growth
In mice with cancer-driving mutations, tumors formed in the liver and skeletal muscle but not the heart. Lung cancer cells grew rapidly in a mechanically unloaded transplanted heart but far less in the same mouse's native heart. In engineered cardiac tissue, tumor growth fell as mechanical stimulation increased.
- Primary cardiac tumors are extremely rare; <1% of autopsies.
- Cardiac metastases occur more often, up to 18% at autopsy.
- Mechanical load from contractions suppresses tumor proliferation in heart models.
- LVAD unloading linked to renewed cardiomyocyte proliferation in humans.
- Nesprin-2 mediates load-induced chromatin changes; early-stage therapeutic target.
4. The Mechanism: Nesprin-2
Mechanical load alters chromatin accessibility, activating genes that suppress cell division. Nesprin-2, a protein in the linker of nucleoskeleton and cytoskeleton complex, appears to relay mechanical signals from the cytoskeleton to the nucleus. Inactivating it allows cancer cells to resume proliferating despite mechanical load.
5. Lessons From the Heart
Researchers are exploring wearable devices that mimic heartbeat-like stimulation for superficial tumors, as well as epigenetic drugs that reproduce the chromatin effects. Both lines of investigation are early-stage and have not been tested in patients.
Bottom Line
Mechanical load from cardiac contractions appears to suppress tumor growth through a Nesprin-2-dependent pathway, possibly explaining the rarity of heart cancer. The concept may extend to other solid tumors, but key questions remain, and therapeutic applications may be years away.
This article is based on a recent Medscape article titled "Why Does the Heart Rarely Develop Cancer?" and was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
